BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

SOPHiA GENETICS and AstraZeneca Expand AI Collaboration to Advance Personalised Breast Cancer Care

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine,announced an expansion of its...

August 06, 2025 | News

Fighting Dengue in a Changing Climate: Takeda’s Vision for Resilient Health Systems in Emerging Markets

Dengue is no longer a seasonal threat. It is a growing climate-driven crisis. With rising global temperatures, shifting rainfall patterns and rapid urbanis...

August 04, 2025 | Expert Insight

Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery

Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...

August 04, 2025 | News

Atombeat and BioDuro Unite to Launch AI-Powered Platform for Next-Gen Peptide Drug Discovery

Atombeat Inc., a leading force in AI for drug discovery, and BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organizatio...

August 04, 2025 | News

Mabwell’s CDH17-Targeting ADC 7MW4911 Receives IND Clearance in China and U.S.

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug ...

August 04, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

August 04, 2025 | News

Thermo Fisher Introduces MagMAX™ HMW DNA Kit to Streamline Long-Read Sequencing Workflows

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction wo...

August 01, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech

Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...

July 31, 2025 | News

Bristol Myers Squibb and Bain Capital Launch New Biotech Company with $300M to Advance Autoimmune Therapies

Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for...

July 29, 2025 | News

Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals

Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...

July 28, 2025 | News

Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...

July 28, 2025 | News

Eppendorf Launches BioBased Safe-Lock Tubes Made from 100% Renewable Materials

The new generation of Safe-Lock Tubes is finally also biobased. "Eppendorf Safe-Lock Tubes BioBased" are made from 100 % renewable biobased feedstock of se...

July 25, 2025 | News

Hillhurst Doses First Patient in Phase 2a Trial of Oral CO Therapy for Sickle Cell Disease

Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products bas...

July 24, 2025 | News

Stay Connected